Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.
Saved in:
| Title: | Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. |
|---|---|
| Authors: | Rangarajan HG; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH., Satwani P; Department of Pediatrics, Columbia University Medical Center, New York, NY., Herr MM; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Chen M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Martens MJ; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI., Wudhikarn K; Center of Excellence in Translational Hematology and Division of Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., John S; Division of Pediatric Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Fabrizio VA; Department of Pediatric Hematology, Oncology, and Bone Marrow Transplant, University of Colorado Anschutz, Aurora, CO., Hsieh EM; Division of Hematology/Oncology/Transplantation & Cellular Therapy, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, CA., Kelkar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Doherty E; Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Hospital/Baylor College of Medicine, Houston, TX., Marks DI; Department of Hematology, Bristol Hematology and Oncology Unit, University of Bristol, Bristol, United Kingdom., Ringden O; Department of Clinical Science, Intervention and Technology, Translational Cell Therapy Group, Karolinska Institute, Stockholm, Sweden., Friend B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX., Kelly MS; Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC., Farhadfar N; Division of Hematology, Sarah Cannon Transplant & Cellular Program at Methodist Hospital, San Antonio, TX., Prestidge T; Department of Blood and Cancer, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand., Hossain NM; Division of Hematology/Oncology - Cell Therapy and Transplantation Program, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA., Liu H; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin-Madison, Madison, WI., Hashmi S; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.; Department of Medicine, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN., Modi D; Division of Oncology, Karmanos Cancer Center, Wayne State University, Detroit, MI., Winestone LE; Division of Allergy, Immunology, and Blood & Marrow Transplant, University of California San Francisco Benioff Children's Hospitals, San Francisco, CA., El Boghdadly Z; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH., Murthy HS; Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, FL., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Chemaly RF; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX., Dandoy CE; Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH., Hill JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA., Huppler A; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Riches M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Auletta JJ; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN.; Hematology, Oncology & Blood and Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH. |
| Source: | Blood advances [Blood Adv] 2025 Nov 11; Vol. 9 (21), pp. 5489-5500. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
